{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:44:12Z","timestamp":1781001852406,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jval.2021.11.1374","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T01:02:47Z","timestamp":1644454967000},"page":"1099-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cost-Effectiveness of Midazolam Versus Haloperidol Versus Olanzapine for the Management of Acute Agitation in the Accident and Emergency Department"],"prefix":"10.1016","volume":"25","author":[{"given":"Vincent K.C.","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Haendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim S.J.","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sik-Hon","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celene Y.L.","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.J.","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11 suppl 2","key":"10.1016\/j.jval.2021.11.1374_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S1092852900008130","article-title":"Management of acute psychosis: from emergency to stabilization","volume":"8","author":"Zimbroff","year":"2003","journal-title":"CNS Spectr"},{"issue":"3","key":"10.1016\/j.jval.2021.11.1374_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jemermed.2005.09.021","article-title":"The use of intramuscular benzodiazepines and antipsychotic agents in the treatment of acute agitation or violence in the emergency department","volume":"31","author":"Rund","year":"2006","journal-title":"J\u00a0Emerg Med"},{"issue":"1","key":"10.1016\/j.jval.2021.11.1374_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annemergmed.2005.07.003","article-title":"Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department","volume":"47","author":"Knott","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jval.2021.11.1374_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jpsychires.2015.07.005","article-title":"Intramuscular olanzapine for agitated patients: a systematic review and meta-analysis of randomized controlled trials","volume":"68","author":"Kishi","year":"2015","journal-title":"J\u00a0Psychiatr Res"},{"issue":"6","key":"10.1016\/j.jval.2021.11.1374_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/1742-6723.12499","article-title":"Management of acute agitation in Hong Kong and comparisons with Australasia","volume":"27","author":"Chan","year":"2015","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.jval.2021.11.1374_bib7","series-title":"Hong Kong\u2019s Health System: Reflections, Perspectives and Visions","year":"2006"},{"key":"10.1016\/j.jval.2021.11.1374_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100751","article-title":"Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: a multi-centre, double-blind, randomised clinical trial","volume":"32","author":"Chan","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.jval.2021.11.1374_bib10","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/hec.1422","article-title":"Equivalence of two healthcare costing methods: bottom-up and top-down","volume":"18","author":"Chapko","year":"2009","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2021.11.1374_bib11","doi-asserted-by":"crossref","first-page":"f1049","DOI":"10.1136\/bmj.f1049","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"346","author":"Husereau","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2021.11.1374_bib12","series-title":"Strategies in Pharmacoeconomics and Outcomes Research","author":"Rychlik","year":"2003"},{"key":"10.1016\/j.jval.2021.11.1374_bib14","unstructured":"Revision to list of charges. Hong Kong Hospital Authority. https:\/\/www.ha.org.hk\/haho\/ho\/cs\/238768_en.pdf. Accessed August 11, 2019."},{"issue":"2","key":"10.1016\/j.jval.2021.11.1374_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","article-title":"Cost-effectiveness analysis alongside clinical trials II\u2014an ISPOR good research practices task force report","volume":"18","author":"Ramsey","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2021.11.1374_bib16","series-title":"Designing Economic Evaluations in Clinical Trials. Economic Evaluation in Clinical Trials","author":"Glick","year":"2007"},{"issue":"1","key":"10.1016\/j.jval.2021.11.1374_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/j.2055-2335.2012.tb00123.x","article-title":"Cost-minimisation analysis of midazolam versus droperidol for acute agitation in the emergency department","volume":"42","author":"Chan","year":"2012","journal-title":"J\u00a0Pharm Pract Res"},{"issue":"8","key":"10.1016\/j.jval.2021.11.1374_bib18","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1592\/phco.29.8.930","article-title":"Intramuscular haloperidol versus intramuscular olanzapine for treatment of acute agitation: a cost-minimization study","volume":"29","author":"Freeman","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.jval.2021.11.1374_bib19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1592\/phco.2005.25.10.1319","article-title":"Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients","volume":"25","author":"Maclaren","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.jval.2021.11.1374_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00019053-199915050-00005","article-title":"Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia","volume":"15","author":"Hamilton","year":"1999","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.jval.2021.11.1374_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1586\/erp.12.53","article-title":"The pharmacoeconomics of managing acute agitation in the emergency department: what do we know and how do we approach it?","volume":"12","author":"Chan","year":"2012","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"4","key":"10.1016\/j.jval.2021.11.1374_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.annemergmed.2010.05.037","article-title":"Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study","volume":"56","author":"Isbister","year":"2010","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.jval.2021.11.1374_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/S1516-44462011000100008","article-title":"Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone","volume":"33","author":"Baldacara","year":"2011","journal-title":"Braz J Psychiatry"},{"issue":"2","key":"10.1016\/j.jval.2021.11.1374_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/inm.12654","article-title":"The effectiveness of chemical restraint in managing acute agitation and aggression: a systematic review of randomized controlled trials","volume":"29","author":"Muir-Cochrane","year":"2020","journal-title":"Int J Ment Health Nurs"},{"issue":"1","key":"10.1016\/j.jval.2021.11.1374_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2012.07.118","article-title":"Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"61","author":"Chan","year":"2013","journal-title":"Ann Emerg Med"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301522000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301522000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:27:37Z","timestamp":1761096457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301522000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1098301522000031"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2021.11.1374","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Midazolam Versus Haloperidol Versus Olanzapine for the Management of Acute Agitation in the Accident and Emergency Department","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2021.11.1374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}